Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020–Sep 2020; Sep 2020–May 2021) in the Veneto Oncology Network: The ROVID study

Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020–Sep 2020; Sep 2020–May 2021) in the Veneto Oncology Network: The ROVID study

We analyzed a cohort of patients with cancer and Sars-Cov-2 infection from the Veneto Oncology Network registry across two pandemic time periods. 761 patients with cancer and SARS-CoV-2 infection were included. 198 patients were diagnosed during the first pandemic time period (TP1; February 2020 Sep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2022-05, Vol.167, p.81-91
Hauptverfasser: Dieci, Maria V., Azzarello, Giuseppe, Zagonel, Vittorina, Bassan, Franco, Gori, Stefania, Aprile, Giuseppe, Chiarion-Sileni, Vanna, Lonardi, Sara, Oliani, Cristina, Zaninelli, Marta, Chiari, Rita, Favaretto, Adolfo, Pavan, Alberto, Di Liso, Elisabetta, Mioranza, Eleonora, Baldoni, Alessandra, Bergamo, Francesca, Maruzzo, Marco, Ziampiri, Stamatia, Inno, Alessandro, Graziani, Filomena, Sinigaglia, Giusy, Celestino, Michele, Conte, Pierfranco, Guarneri, Valentina
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
COVID-19
COVID-19 - epidemiology
Hospitalization
Humans
Immunization
Infections
Mortality
Neoplasms - epidemiology
Oncology
Original Research
Pandemics
Patients
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Vaccination
Viral diseases
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We analyzed a cohort of patients with cancer and Sars-Cov-2 infection from the Veneto Oncology Network registry across two pandemic time periods. 761 patients with cancer and SARS-CoV-2 infection were included. 198 patients were diagnosed during the first pandemic time period (TP1; February 2020 September 2020), 494 during TP2 before the vaccination campaign (TP2/pre-vaccination; September 2020-21 February 2021) and 69 in TP2/post-vaccination (22 February 2021-15 May 2021). TP2 vs TP1 patients were younger (p = 0.004), showed more frequently a good performance status (p < 0.001) and
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2022.03.005